Copyright Reports & Markets. All rights reserved.

Global Post herpetic Neuralgia Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Post herpetic Neuralgia Treatment Market Overview

    • 1.1 Product Overview and Scope of Post herpetic Neuralgia Treatment
    • 1.2 Classification of Post herpetic Neuralgia Treatment by Types
      • 1.2.1 Global Post herpetic Neuralgia Treatment Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Types in 2018
      • 1.2.3 Anticonvulsants
      • 1.2.4 Skin Patch
      • 1.2.5 Other
    • 1.3 Global Post herpetic Neuralgia Treatment Market by Application
      • 1.3.1 Global Post herpetic Neuralgia Treatment Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Online Pharmacies
      • 1.3.4 Retail Pharmacies
    • 1.4 Global Post herpetic Neuralgia Treatment Market by Regions
      • 1.4.1 Global Post herpetic Neuralgia Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Post herpetic Neuralgia Treatment Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Post herpetic Neuralgia Treatment Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Post herpetic Neuralgia Treatment Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Post herpetic Neuralgia Treatment Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Post herpetic Neuralgia Treatment Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Post herpetic Neuralgia Treatment (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Business Overview
      • 2.1.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Pfizer Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Arbor Pharma
      • 2.2.1 Business Overview
      • 2.2.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Assertio Therapeutics
      • 2.3.1 Business Overview
      • 2.3.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Endo Pharma
      • 2.4.1 Business Overview
      • 2.4.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Endo Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Teikoku Pharma
      • 2.5.1 Business Overview
      • 2.5.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Teva
      • 2.6.1 Business Overview
      • 2.6.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Teva Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Mylan
      • 2.7.1 Business Overview
      • 2.7.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Mylan Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Hengrui Medicine
      • 2.8.1 Business Overview
      • 2.8.2 Post herpetic Neuralgia Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Post herpetic Neuralgia Treatment Market Competition, by Players

    • 3.1 Global Post herpetic Neuralgia Treatment Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Post herpetic Neuralgia Treatment Players Market Share
      • 3.2.2 Top 10 Post herpetic Neuralgia Treatment Players Market Share
    • 3.3 Market Competition Trend

    4 Global Post herpetic Neuralgia Treatment Market Size by Regions

    • 4.1 Global Post herpetic Neuralgia Treatment Revenue and Market Share by Regions
    • 4.2 North America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 4.5 South America Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    5 North America Post herpetic Neuralgia Treatment Revenue by Countries

    • 5.1 North America Post herpetic Neuralgia Treatment Revenue by Countries (2014-2019)
    • 5.2 USA Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    6 Europe Post herpetic Neuralgia Treatment Revenue by Countries

    • 6.1 Europe Post herpetic Neuralgia Treatment Revenue by Countries (2014-2019)
    • 6.2 Germany Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 6.3 UK Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 6.4 France Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Countries

    • 7.1 Asia-Pacific Post herpetic Neuralgia Treatment Revenue by Countries (2014-2019)
    • 7.2 China Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 7.5 India Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    8 South America Post herpetic Neuralgia Treatment Revenue by Countries

    • 8.1 South America Post herpetic Neuralgia Treatment Revenue by Countries (2014-2019)
    • 8.2 Brazil Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Post herpetic Neuralgia Treatment by Countries

    • 9.1 Middle East and Africa Post herpetic Neuralgia Treatment Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Post herpetic Neuralgia Treatment Revenue and Growth Rate (2014-2019)

    10 Global Post herpetic Neuralgia Treatment Market Segment by Type

    • 10.1 Global Post herpetic Neuralgia Treatment Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Post herpetic Neuralgia Treatment Market Forecast by Type (2019-2024)
    • 10.3 Anticonvulsants Revenue Growth Rate (2014-2024)
    • 10.4 Skin Patch Revenue Growth Rate (2014-2024)
    • 10.5 Other Revenue Growth Rate (2014-2024)

    11 Global Post herpetic Neuralgia Treatment Market Segment by Application

    • 11.1 Global Post herpetic Neuralgia Treatment Revenue Market Share by Application (2014-2019)
    • 11.2 Post herpetic Neuralgia Treatment Market Forecast by Application (2019-2024)
    • 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
    • 11.4 Online Pharmacies Revenue Growth (2014-2019)
    • 11.5 Retail Pharmacies Revenue Growth (2014-2019)

    12 Global Post herpetic Neuralgia Treatment Market Size Forecast (2019-2024)

    • 12.1 Global Post herpetic Neuralgia Treatment Market Size Forecast (2019-2024)
    • 12.2 Global Post herpetic Neuralgia Treatment Market Forecast by Regions (2019-2024)
    • 12.3 North America Post herpetic Neuralgia Treatment Revenue Market Forecast (2019-2024)
    • 12.4 Europe Post herpetic Neuralgia Treatment Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Post herpetic Neuralgia Treatment Revenue Market Forecast (2019-2024)
    • 12.6 South America Post herpetic Neuralgia Treatment Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Post herpetic Neuralgia Treatment Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

      Scope of the Report:
      The classification of Post herpetic Neuralgia Treatment includes Anticonvulsants, Skin Patch and others, and the proportion of Anticonvulsants in 2018 is about 81.7%.
      Post herpetic Neuralgia Treatment is widely used for Hospital Pharmacies, Online Pharmacies and Retail Pharmacies. The Hospital Pharmacies is major application it accounts for about 52% market share in 2018.
      The global Post herpetic Neuralgia Treatment market is valued at 1453.9 million USD in 2018 and is expected to reach 1751.1 million USD by the end of 2024, growing at a CAGR of 3.8% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Post herpetic Neuralgia Treatment.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Post herpetic Neuralgia Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Post herpetic Neuralgia Treatment market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Pfizer
      Arbor Pharma
      Assertio Therapeutics
      Endo Pharma
      Teikoku Pharma
      Teva
      Mylan
      Hengrui Medicine

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Anticonvulsants
      Skin Patch
      Other

      Market Segment by Applications, can be divided into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Buy now